Loading company…
UK biopharma offering drug discovery services that apply structure-based methods to complex therapeutic targets.
Founded in 1988 in the UK, Vernalis PLC provides drug discovery services, applying over 25 years of structure-based methods to complex therapeutic targets. Clients include Servier, Pierre Fabre and Genentech. Ligand Pharmaceuticals, Inc. acquired Vernalis for GBP 32.80 million on August 9, 2018. In 2024 it reported revenue of GBP 16,373,955.60 and an EBITDA of GBP 2,971,621.80.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in